| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 20 |
| 1 | ETOPOSIDE | 17 |
| 2 | RITUXIMAB | 15 |
| 3 | ANAKINRA | 13 |
| 4 | HYDROCORTISONE | 13 |
| 5 | ANTI ITCH | 12 |
| 6 | ANTI-ITCH | 12 |
| 7 | ANTI-ITCH CREAM | 12 |
| 8 | ANTI-PRURITIC | 12 |
| 9 | ANTIPRURITIC (ANTI-ITCH) | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORASIDENIB | 1 | 0.0016 |
| 1 | MITOMYCIN | 5 | 0.0014 |
| 2 | NELARABINE | 1 | 0.0010 |
| 3 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 4 | ALGLUCOSIDASE ALFA | 2 | 0.0008 |
| 5 | ANAKINRA | 13 | 0.0008 |
| 6 | VECURONIUM BROMIDE | 1 | 0.0007 |
| 7 | BLEOMYCIN SULFATE | 6 | 0.0006 |
| 8 | VANDETANIB | 1 | 0.0006 |
| 9 | ISOFLURANE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 3 | 0.0009 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 13 | 0.0008 |
| 2 | Neonatal Fc Receptor Blocker [EPC] | 3 | 0.0007 |
| 3 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 1 | 0.0005 |
| 4 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 5 | Topoisomerase Inhibitor [EPC] | 18 | 0.0002 |
| 6 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 9 | Complement Inhibitor [EPC] | 5 | 0.0001 |